Ross Penglase
@rosspenglase
Rheumatologist based in Sydney, PhD candidate (scleroderma/systemic sclerosis), husband and dad.
ID: 1452916267
24-05-2013 00:59:11
231 Tweet
197 Followers
214 Following
Please register. It is free but is needed for participation! #CTD-ILD World Scleroderma Foundation U-M Department of Internal Medicine EUSTAR Vincent Cottin @PhilippeDieude 3RD International Symposium on Interstitial Lung Disease in Rheumatic Diseases Register by going to: internationalild.ch/Click
Hot take: Methotrexate does not cause liver fibrosis It’s ok to be cautious (periodic fibroscan). It’s ok to use MTX initiation as a trigger to look for fibrosis in at risk people (eg diabetes). But Time to turn the page pubmed.ncbi.nlm.nih.gov/36702175/ Edmond Atallah #livertwitter
I had grown accustomed to stating “it’s not possible to reliably locate the source of low back pain” Then Chris Han completed this DTA review and I had to rethink Published in Lancet Discovery Sci eClinicalMedicine – The Lancet Discovery Science Great team and what a PhD paper! sciencedirect.com/science/articl…
Just Out! VKPrasadLab The definition of long COVID in trials to treat it Only 54% require that you had COVID! There were 8 different time durations and 57 different symptoms to be included This field is a DISASTER Lack of standards hurts sufferers! onlinelibrary.wiley.com/doi/epdf/10.11…
Moderate ILD in myositis: Prednisone 1 mg/kg (up to 60 mg) + MMF or AZA Consider add tacro, RTX, IVIg No difference bw MMF/AZA, trend toward more deaths in AZA group RIM trial: RTX 24% FVC improvement tho not prim endothelial Tacro: good non-random data Dr. John Cush #ACRX23
We found a novel link between a microbe and multiple sclerosis (MS). Strains of Clostridium perfringens that make an epsilon toxin were enriched in people with MS, linking a bacterial toxin with a neurological disorder. Featured today on the cover of Journal of Clinical Investigation!
Hot off the Press: International Guidelines on Cancer Screening for Myositis are published. Start doing the risk based stratification and cancer screening for your myositis patient. Thanks to Alexander Oldroyd for his scientific acumen and hard work. nature.com/articles/s4158…